Eclipse Corporate Finance advises on the secondary management buy-out of Sano Physiotherapy backed by Bestport Private Equity

We are delighted to have advised the shareholders of Sano Physiotherapy on the secondary management buy-out backed by Bestport Private Equity.

Deal Overview

Sano Physiotherapy offers physiotherapy and ergonomic assessments to a wide range of clients, including public and private sector organisations, private clients, case handlers and the NHS.

Since its founding in 2010, it has seen substantial growth – particularly in the occupational health and private patient sectors – driven by a combination of organic expansion and strategic acquisitions.

The investment from Bestport will support the continuation and scaling of this growth strategy. Founder and CEO Matt Taylor will remain at the helm of the business, as he has since its inception.

Th deal represents a strong return for incumbent investor, Solingen Private Equity, who backed Sano in 2017 and have supported the growth journey in recent years.

Sano currently operates 43 clinic sites and employs over 100 full-time staff across Yorkshire, the North East, Derby, Nottingham, Leicester, and the Midlands, while delivering occupational health physiotherapy services nationwide.

Taylor said: “I’m looking forward to working with Bestport as we continue to scale Sano. With Bestport’s backing, we are ideally positioned to accelerate our strategy of acquisitive expansion and uncover unique opportunities for partnership and growth.”

Bestport provides private equity to established, fast growing, cash-generative UK companies valued between £3m and £40m to support their organic growth.

Eclipse Corporate Finance's Role

Eclipse were appointed by the shareholders of Sano (consisting of Solingen Private Equity and Matt Taylor) to consider exit options.

A highly competitive sale process was run by Eclipse involving both strategic trade acquirers and private equity investors, with Bestport being selected as the preferred partner.